Skip to main content
. Author manuscript; available in PMC: 2022 May 3.
Published in final edited form as: Epidemiology. 2020 May;31(3):334–344. doi: 10.1097/EDE.0000000000001177

Table 1:

Results from analyses using the multi-center HALT-C trial data to emulate a meta-analysis.

S Sample size Unadjusted Treatment effect modeling Weighting
1 48 −29.3 (−70.0, 11.5) −50.9 (−75.8, −25.9) −48.9 (−76.8, −20.9)
2 98 −42.3 (−68.1, −16.4) −29.9 (−42.8, −17.0) −23.3 (−46.5, −0.2)
3 133 −43.3 (−66.1, −20.4) −31.2 (−44.2, −18.2) −27.4 (−50.0, −4.7)
4 69 −24.0 (−50.6, 2.6) −35.3 (−52.5, −18.1) −26.9 (−49.0, −4.8)
5 77 −71.8 (−97.7, −45.9) −63.5 (−77.6, −49.5) −49.5 (−76.9, −22.1)
6 110 −38.0 (−62.2, −13.8) −33.4 (−54.3, −12.6) −32.3 (−56.8, −7.8)
7 94 −43.2 (−72.9, −13.5) −60.6 (−83.5, −37.7) −54.7 (−97.6, −11.9)
8 100 −49.7 (−72.9, −26.6) −54.0 (−71.1, −37.0) −57.0 (−77.7, −36.3)
9 43 −24.6 (−57.0, 7.7) −48.8 (−68.7, −28.8) −33.9 (−61.7, −6.2)
0 202 −45.7 (−63.6, −27.9) −43.7 (−52.2, −35.2) −42.4 (−52.6, −32.3)

Point estimates and 95% confidence intervals (in parentheses) from analyses using the multi-center HALT-C trial data to emulate a meta-analysis. Unadjusted results are obtained using the crude mean difference in each trial for all rows. Treatment effect modeling results are obtained using the estimator of equation (6) in rows 1 through 9 and estimator (8) in the bottom row; weighting results are obtained using the estimator of equation (7) in rows 1 through 9 and estimator (9) in the bottom row. In rows 1 through 9, for each trial unadjusted results use only treatment and outcome data from each trial sS; transportability analyses use covariate, treatment, and outcome data from each trial sS and baseline covariate data from S = 0. In the bottom row, the unadjusted analysis uses only treatment and outcome data from the center S = 0; transportability analyses use covariate, treatment, and outcome data from all trials in the collection S and baseline covariate data from S = 0.